Volume 52, Number 11 November 2023
Gram-negative bacteria are found to be frequently multidrug-resistant and the predominant cause of infections among preterm infants in the neonatal intensive care unit.
Read Burden of antibiotic resistance in infections among very-low-birthweight infants in Singapore, published in the November issue of the Annals.
AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management
Outcomes of a targeted congenital cytomegalovirus infection screening approach among infants born ≥35...
Association of quality-of-care indicators with asthma outcomes: A retrospective observational study for asthma...
Call For Papers
The Annals is the official journal of the Academy of Medicine, Singapore. Established in 1972, Annals is the leading medical journal in Singapore which aims to publish novel findings from clinical research as well as medical practices that can benefit the medical community.
Published monthly, online, open-access and peer-reviewed, Annals is indexed in Science Citation Index Expanded, Current Contents/Clinical Medicine and SCOPUS. The journal’s 2022 Impact Factor is 5.2. It is ranked in the first quartile in the competitive category of Medicine (General and Internal) and second among medical journals in Asia. As we are transitioning to an Online Only journal, there may be a delay in PubMed indexing for our content.
The rapidly ageing population and enlarging burden of chronic diseases require a proportionate emphasis on health promotion and disease prevention. A health system that is more data-driven and patient-centric, which leverages the innovative use of technology and digital solutions, will be areas warranting research attention and coverage. The Annals invites submission of manuscripts that advance the scientific basis of clinical knowledge, and the practice of medicine in Singapore and internationally. We welcome submissions that address challenges in the management of chronic diseases (e.g. cancer, cardiovascular diseases, ageing, diabetes mellitus and neurological diseases), and use of technology and digital medicine to improve patient care.Papers of sufficient merits will be published. Authors will also be notified if their manuscripts are deemed not suitable for publication.